SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2009 / Cilt: 43 - Sayı: 3

An adolescent prolactinoma presented with menometrorrhagia: Case report

Menometroraji ile baflvuran bir adolesanda prolaktinoma: Olgu sunumu

EMRAH CAN
İLHAN ASYA TANJU
Selami SÜLEYMANOĞLU
Ferhan KARADEMİR
İsmail GÖÇMEN
Pages
134–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, a 14 year-old adolescent presenting with irreguler and frequent vaginal hemorrhage (menometrorrhagia) who was diagnosed to have prolactinoma is reported.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prolactinomas are benign pituitary tumors that are frequently seen in females aged 20 to 50 years old.
📊
Key Findings & Data:The female-to-male ratio is approximately 10:1.
💡
Conclusion & Impact:In this case report, a 14 year-old adolescent presenting with irreguler and frequent vaginal hemorrhage (menometrorrhagia) who was diagnosed to have prolactinoma is reported.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Prolaktinom · Ergen · Kadın

Abstract

Prolactinomas are benign pituitary tumors that are frequently seen in females aged 20 to 50 years old. The female-to-male ratio is approximately 10:1. In pediatric-adolescent age group, prolactinomas have a prevalence of 100/million population, and account for less than 2% of all intracranial tumors. The symptoms are abnormal uterine bleeding, pubertal arrest, hypogonadism and galactore. In this case report, a 14 year-old adolescent presenting with irreguler and frequent vaginal hemorrhage (menometrorrhagia) who was diagnosed to have prolactinoma is reported.

Özet

Prolaktinoma çoğunluğu selim karakterli yaygın bir hipofiz tümörüdür. Kız/erkek oranı 10/1’dir. Adolesan çağın intrakraniyal tümörlerinin %2 kadarını prolaktinoma oluşturmaktadır. Prevalansı 100/1.000.000 olarak bildirilmektedir. Başlıca klinik bulguları düzensiz kanama, pubertede duraklama, hipogonadizm ve galaktoredir. Bunun yanı sıra bazı olgularda kitle etkisine bağlı olarak başağrısı ve görme ile ilgili sorunlar bildirilmiştir. Bu yazıda sık ve düzensiz olan adet kanaması (menometroraji) ile başvuran 14 yaşında bir adolesanda prolaktinoma olgusunun vurgulanması amaçlanmıştır.

🔖

Cite This Article

CAN, E., TANJU, İ. A., SÜLEYMANOĞLU, S., KARADEMİR, F., GÖÇMEN, İ. (2009). An adolescent prolactinoma presented with menometrorrhagia: Case report. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 43 - Sayı: 3, 134–136. https://ajindex.com/articles/363884

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Casanueva FF, Molitch ME, Schlechte JA, et al: Guidelines of Pituitary Society for the diagnosis and management of prolactinomas. Clinical Endocrinology, 65: 265-273,2006
  2. Ciccarelli A, Daly AF, Beckers A: The epidemiology of prolactinomas. Pituitary, (1):3-6,2005
  3. Thibaud E, Samara-Boustani D, Duflos-Cohade C: Menometrorraghia in adolescents. Arch Pediatr, 15(5):584-5,2008
  4. Fideleff HL, Boquete HR, Sequera A, et al: Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. Journal of Pediatric Endocrinology and Metabolism,13:261-67,2000
  5. Huang AP, Yang SH, Yang CC,et al: Malignant prolactinoma with craniospinal metastasis in a 12-year-old boy. J Neurooncol,90(1):41-6,2008
  6. Gamba G, Cisternino M, Kasirye I, et al: Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis? Minerva Pediatr, 53(5):479-80,2001
  7. Molitch ME: Medical management of prolactin-secreting pituitary adenomas. Pituitary, 5:55-65,2002
  8. Naidich MJ, Russell EJ: Current approaches to imaging of the sellar region and pituitary. Endocrinology and Metabolism Clinics of North America, 28:45–79,1999
  9. Verhelst J, Abs R, Maiter D, et al: Cabergoline in thetreatment of hyperprolactinaemia: a study in 455 patients. Journal of Clinical Endocrinology and Metabolism, 84: 2518-2522,1999
  10. Colao A, Di Sarno A, Cappabianca P, et al: Gender differences in the prevalence,clinical features and response to cabergoline inhyperprolactinemia. Eur J Endocrinol,148:325–331,2003.